Dihidrogenofosfato

Fosfato Monosodico 1M Fresenius Kabi 120 MG/ML Concentrado Para Solucion Para Perfusion

1200 mg solución inyectableSpainMarketedAuthorised 27 Dec 2000

Packs

Pack	Code	Status
FOSFATO MONOSODICO 1M FRESENIUS KABI 120 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION , 100 ampollas de 10 ml	600210
FOSFATO MONOSODICO 1M FRESENIUS KABI 120 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION , 1 ampolla de 10 ml	665554
FOSFATO MONOSODICO 1M FRESENIUS KABI 120 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION 10 ampollas de 10 ml	726520

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Dihidrogenofosfato

Fosfato Monosodico 1M Fresenius Kabi 120 MG/ML Concentrado Para Solucion Para Perfusion

1200 mg solución inyectableSpainMarketedAuthorised 27 Dec 2000

Product informationAsk Osler about it

Packs

Pack	Code	Status
FOSFATO MONOSODICO 1M FRESENIUS KABI 120 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION , 100 ampollas de 10 ml	600210
FOSFATO MONOSODICO 1M FRESENIUS KABI 120 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION , 1 ampolla de 10 ml	665554
FOSFATO MONOSODICO 1M FRESENIUS KABI 120 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION 10 ampollas de 10 ml	726520

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Dihidrogenofosfato
Strength: 1200 mg
Dosage form: solución inyectable
Route: vía intravenosa
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 27 Dec 2000
Registration: 63545
Marketing authorisation holder: Fresenius Kabi España, S.A.U.
Procedure: National, MRP or DCP
Supply: Uso Hospitalario